WO2025253283 - POLYSACCHARIDE-BASED COMPOSITION
National phase entry is expected:
Publication Number
WO/2025/253283
Publication Date
11.12.2025
International Application No.
PCT/IB2025/055693
International Filing Date
03.06.2025
Title **
[English]
POLYSACCHARIDE-BASED COMPOSITION
[French]
COMPOSITION À BASE DE POLYSACCHARIDE
Applicants **
HALEON US HOLDINGS LLC
Inventors
PAN, Huiqi
ZHENG, Hui
LU, Gaosheng
Priority Data
202410711002.5
03.06.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2110 | |
| EPO | Filing, Examination, Granting | 9698 | |
| Japan | Filing, Examination, Granting | 2264 | |
| South Korea | Filing, Examination, Granting | 2236 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,048
Contact Us
Abstract[English]
Disclosed is a composition comprising a polysaccharide and a first acid, the polysaccharide comprising sucrose and a maltodextrin, the first acid comprising citric acid, malic acid, and/or tartaric acid, wherein the weight ratio of the maltodextrin to the first acid is 2:1 or higher. Further disclosed a formulation prepared from the composition. Also disclosed is a composition of oral dry powder formulation comprising a polysaccharide and a first acid, the polysaccharide comprising sucrose and a maltodextrin, the first acid comprising citric acid, malic acid, and/or tartaric acid, and the composition further comprising acetaminophen (APAP) and another active pharmaceutical ingredient different from acetaminophen (APAP), wherein the weight ratio of the maltodextrin to the first acid is 2:1 or higher.[French]
L'invention concerne une composition contenant un polysaccharide et un premier acide, le polysaccharide comprenant du saccharose et une maltodextrine, le premier acide comprenant de l'acide citrique, de l'acide malique et/ou de l'acide tartrique, le rapport en poids de la maltodextrine au premier acide étant supérieur ou égal à 2:1. L'invention concerne en outre une formulation préparée à partir de la composition. L'invention concerne également une composition de formulation de poudre sèche orale contenant un polysaccharide et un premier acide, le polysaccharide comprenant du saccharose et une maltodextrine, le premier acide comprenant de l'acide citrique, de l'acide malique et/ou de l'acide tartrique, et la composition contenant en outre de l'acétaminophène (APAP) et un autre ingrédient pharmaceutique actif différent de l'acétaminophène (APAP), le rapport en poids de la maltodextrine au premier acide étant supérieur ou égal à 2:1.